Skip to main content
. 2021 Sep 28;12(20):2006–2021. doi: 10.18632/oncotarget.28075

Figure 1. Drug-specific variability in the kinetics of the p53 response to 5-FU, CPT-11, oxaliplatin, and cisplatin in human colorectal cancer cells.

Figure 1

HCT116 and HCT116 p53−/− cells were treated with 5-FU, CPT-11, oxaliplatin, and cisplatin at their respective IC50s at various time points.